Patent · US Active

1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as SGRM modulators

US10196374B2 · kind B2 · utility

1Cited by

0References

15Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Lena Elisabeth Ripa · Lund, SE
Karolina Lawitz · Malmö, SE
Matti Lepisto · Lund, SE
Martin Hemmerling · Timrå, SE
Karl Edman · Timrå, SE
Antonio Llinas · Timrå, SE

Key dates

Filing date	Sep 23, 2015
Grant date	Feb 5, 2019
Priority date	—
Expiry date	Sep 23, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This specification generally relates to 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds (including salts thereof). This specification also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including treatment methods and medicament preparations), and processes for making such a compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.